Anna Berkenblit
2019
Compensation breakdown
| Non-Equity Incentive Plan | $132,288 |
|---|---|
| Option Awards | $1,206,019 |
| Salary | $461,367 |
| Other | $9,030 |
| Total | $1,808,704 |
Berkenblit received $1.2M in option awards, accounting for 67% of the total pay in 2019.
Berkenblit also received $132.3K in non-equity incentive plan, $461.4K in salary and $9K in other compensation.
Rankings
In 2019, Anna Berkenblit's compensation ranked 6,428th out of 13,971 executives tracked by ExecPay. In other words, Berkenblit earned more than 54.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,428 out of 13,971 | 54th |
Division Manufacturing | 2,431 out of 5,701 | 57th |
Major group Chemicals And Allied Products | 890 out of 2,200 | 60th |
Industry group Drugs | 755 out of 1,886 | 60th |
Industry Pharmaceutical Preparations | 554 out of 1,398 | 60th |
Pay ratio
| Anna Berkenblit's Pay | $1,808,704 |
|---|---|
| Median Employee's Pay | $223,674 |
| Pay Ratio | 8to 1 |
In 2019, the annual total compensation of Anna Berkenblit was $1,808,704.
The annual total compensation of the median employee at ImmunoGen was $223,674.
The ratio of Anna Berkenblit's pay to the pay of median employee was therefore 8 to one.
Berkenblit's colleagues
We found five more compensation records of executives who worked with Anna Berkenblit at ImmunoGen in 2019.
2019
Mark Enyedy
ImmunoGen
Chief Executive Officer
2019
Richard Gregory
ImmunoGen
Chief Scientific Officer
2019
Thomas Ryll
ImmunoGen
Senior Vice President, Technical Operations
2019
Craig Barrows
ImmunoGen
General Counsel
2019
Theresa Wingrove
ImmunoGen